Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8410264 Heterocyclic oxime compounds

Patent 8410264 was granted and assigned to Novartis on April, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8410264

Patent Inventor Names

Yue Li0

Zhengtian Yu0

Fang Liang0

Feng He0

Guoliang Xun0

Ji Yue Zhang0

Lei Jiang0

Lei Liu0

...

Date of Patent

April 2, 2013

Patent Application Number

12859653

Date Filed

August 19, 2010

Patent Citations Received

‌

US Patent 11773097 Polymorphs of sepiapterin and salts thereof

‌

US Patent 11752154 Pharmaceutical compositions comprising sepiapterin and uses thereof

Patent Primary Examiner

‌

Venkataraman Balasubramanian

Patent abstract

The invention relates to compounds of formula (I) and salts thereof:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8410264 Heterocyclic oxime compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API